June 9, 2020 / 11:51 AM / a month ago

BRIEF-Kalytera Announces Data From Study In Rats Demonstrating Proof Of Concept For R-107 In COVID-19 Associated PAH

June 9 (Reuters) - Kalytera Therapeutics Inc:

* KALYTERA THERAPEUTICS INC - ANNOUNCES DATA FROM STUDY IN RATS DEMONSTRATING PROOF OF CONCEPT FOR R-107 IN COVID-19 ASSOCIATED PAH

* KALYTERA THERAPEUTICS INC - DATA SIGNIFY THAT R-107 SELECTIVELY LOWERED PAH AND DID NOT COMPROMISE PERIPHERAL HEMODYNAMICS

* KALYTERA - STUDY RESULTS DEMONSTRATE POTENTIAL OF R-100 TO SELECTIVELY LOWER BLOOD PRESSURE IN LUNG WHILE LEAVING PERIPHERAL BLOOD PRESSURE UNCHANGED

* KALYTERA - PLANS TO SUBMIT AN IND TO AUSTRALIAN TGA, U.S FDA FOR CLINICAL STUDY OF R-107 IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below